Insiders Updates
Bolt Biotherapeutics Inc (BOLT) gets rating Downgrade from Morgan Stanley
Bolt Biotherapeutics Inc’s recently made public that its Chief Financial Officer Quinn William P. acquired Company’s shares for reported $7125.0
Menu